Trouble viewing this email? Read it on the Web here.
Golden Helix Newsletter
 
Golden Helix Featured in Various Publications
Golden Helix Featured in Various Publications
by Delaina Hawkins
Marketing Manager


Following a wonderful September with our 20th Anniversary and being awarded an NIH-SBIR Phase 2 Grant, October has been nothing short of exciting for us here at Golden Helix. We know that none of our success could happen without the continuous support all of you show us � so thank you to everyone who is a part of this awesome community...
Continue Reading �

We're Headed to AMP 2018
We're Headed to AMP 2018

November 1-3, 2018 | San Antonio, TX

Please stop by and say hello to the Golden Helix team in booth #1801. We have a variety of demos planned that we hope you'll attend! Afterwards, we will be handing out our famous t-shirts!

See the full demo schedule �

We're Headed to AMP 2018
Using the GRCh38 Reference Assembly for Clinical Interpretation in VSClinical � Webcast Recap
by Cody Sarrazin, Ph.D
Product Specialist Scientist


Even though GRCh37 is currently the most widely used human genome assembly, GRCh38 provides a more complete human reference genome, offers more accurate genomic analysis, and includes centromere and mitochondrial information. However, we�re getting ahead of ourselves. Perhaps start with how we got here�
Continue Reading �
   CEO Corner
Andreas Scherer
We have just returned to the office after a great week at ASHG in San Diego, CA. This conference was a big success for us with a record number of visitors stopping by our booth and CoLab presentations. Also during this time, we were featured in several different media outlets. I had the pleasure of interviewing one-on-one with both GenomeWeb and Bio-IT World to discuss our recent grant as well as future development plans. I covered, in particular, further advances in structural variation detection, embedding those into clinical workflows and our accelerated usage of AI technologies to assist in the clinical decision making. You can view the entire collection of these featured articles here. Now, we are off to AMP in San Antonio, TX! We look forward to seeing all of you who will be attending. Please stop by our booth #1801 and say hello!
 
  Recent Webcast
Annotating and Cataloging CNVs in VarSeq

Watch the Webcast Recording

We show users the process of annotating and filtering CNVs in VarSeq. This will include a discussion of available annotation sources and a demonstration of how these annotations may be utilized in VarSeq filter chains to identify clinically relevant CNVs. We will also discuss CNV assessment catalogs as a mechanism for tracking common CNVs and identifying relevant previously classified events.
 
Facebook     Twitter     Linked In     Blog   YouTube


About Golden Helix
Golden Helix� is a global bioinformatics firm founded in 1998. Our largest outside investor is GlaxoSmithKline who invested early on into the company. We develop and sell an industry leading clinical solution that supports the analysis of sequencing data and the creation of clinical reports. Clinicians and researchers worldwide trust our solution. Over all these years we have accumulated a significant customer base conducting business with over 400 organizations globally with thousands of users leveraging our various analytics products. Our customers fall into five categories: Large Hospitals, Genetic Testing Labs, Pharmaceutical companies, major research organizations, and government organizations here in the US and internationally. Our work his referenced in over 1,300 publications such as Science, Nature and Nature Genetics.
 



Copyright 2018 Golden Helix, Inc. All Rights Reserved.
Golden Helix, Inc. | 203 Enterprise, Blvd. | Bozeman, MT | 59718
View our Privacy Policy | Unsubscribe